Toronto, September 29, 2020 (Global News)-Aleafia Health Inc. (Toronto Stock Exchange: AH, OTC: ALEAF) ("
") is pleased to announce the release and release of 510 vape cartridges, which represent the company's first Cannabis 2.0 product format on the market.
"This is an important milestone and represents our first step into the adult use market in a meaningful way, while strengthening our expanding medical cannabis market share. We look forward to a series of excitement in the coming months. With the launch of Renxin products, we will continue to introduce new innovative forms to the market while expanding our core product portfolio." said Geoffrey Benic, CEO of Aleafia Health.
Nicholas Bergamini, Vice President of Investor Relations
Aleafia Health is a vertically integrated company licensed by the Canadian Federal Government to provide cannabis healthcare services in the Canadian and international markets. The company operates medical clinics, education centers and production facilities to produce and sell cannabis.
Aleafia Health owns three important licensed cannabis production facilities, including the first large-scale legal outdoor cultivation facility in Canadian history. The company produces a variety of commercially proven high-margin derivative products, including oils, capsules and sprays. Aleafia Health has the largest national network of medical cannabis clinics and education centers composed of doctors of medicine, nurse practitioners and educators, and has international operations on three continents.
Innovation is at the core of Aleafia Health's competitive advantage. It allows the company to maintain a medical marijuana dataset containing more than 10 million data points to inform the development of proprietary products for specific diseases and its highly differentiated education platform FoliEdge Academy. The company is committed to creating sustainable shareholder value; before graduating from the Toronto Stock Exchange, the TSX Venture Exchange ranked Aleafia as the best performing company in 2019.
This press release contains forward-looking information as defined by applicable Canadian and U.S. securities laws. Usually, but not always, forward-looking information can be identified by using words such as "plan", "expected" or "unexpected", "expected", "estimated", "intended", "anticipated" and the like. Or "unexpected", "believe" or variations of such words and phrases, or a statement that "may", "may", "will", "may" or "will" take certain actions, events, or The result may be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company or its subsidiaries to be materially related to any future results, performance or achievements implied by the forward-looking statements or Discrepancies with the information contained in this press release. The risks, uncertainties and other factors involved in forward-looking information may cause actual events, results, performance, prospects and opportunities to be materially different from those expressed or implied by such forward-looking information, including the company’s annual information submitted to the company The risks included in the table. For information about Canadian securities regulators, please visit the company’s SEDAR profile at:
. Although the company believes that the assumptions and factors used to prepare forward-looking information in this press release are reasonable, it should not rely excessively on such information, nor can it guarantee that such events will be within the disclosed time frame or not at all. The forward-looking information contained in this press release has been released from the date of this press release. Unless applicable securities requirements, the company assumes no obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise. legislation.
Concord, Ontario, Canada